We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,108 hedge funds and large institutions have $257B invested in Johnson & Johnson in 2024 Q4 according to their latest regulatory filings, with 471 funds opening new positions, 1,352 increasing their positions, 1,937 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more first-time investments, than exits

New positions opened: 471 | Existing positions closed: 177

25% more call options, than puts

Call options by funds: $2.65B | Put options by funds: $2.11B

6% more funds holding

Funds holding: 3,8854,108 (+223)

0.54% more ownership

Funds ownership: 71.49%72.03% (+0.54%)

8% less capital invested

Capital invested by funds: $278B → $257B (-$20.9B)

24% less funds holding in top 10

Funds holding in top 10: 191146 (-45)

30% less repeat investments, than reductions

Existing positions increased: 1,352 | Existing positions reduced: 1,937

Holders
4,108
Holders Change
+223
Holders Change %
+5.74%
% of All Funds
54.07%
Holding in Top 10
146
Holding in Top 10 Change
-45
Holding in Top 10 Change %
-23.56%
% of All Funds
1.92%
New
471
Increased
1,352
Reduced
1,937
Closed
177
Calls
$2.65B
Puts
$2.11B
Net Calls
+$534M
Net Calls Change
-$67.5M
Name Holding Trade Value Shares
Change
Change in
Stake
SIA
1226
Soltis Investment Advisors
Utah
$5.2M -$247K -1,597 -4%
FRA
1227
Frank Rimerman Advisors
California
$5.2M +$15.5K +100 +0.3%
PIM
1228
Platinum Investment Management
Australia
$5.2M
BST
1229
Bath Savings Trust
Maine
$5.19M -$403K -2,600 -7%
IMC Chicago
1230
IMC Chicago
Illinois
$5.18M +$5.55M +35,847 New
HI
1231
Harbour Investments
Wisconsin
$5.18M -$50.7K -327 -0.9%
BCA
1232
Bernzott Capital Advisors
California
$5.18M -$547K -3,528 -9%
BMA
1233
Brooks Moore & Associates
Tennessee
$5.16M +$144K +932 +3%
JIP
1234
Jaffetilchin Investment Partners
Florida
$5.15M +$183K +1,179 +3%
MSA
1235
MUFG Securities Americas
New York
$5.14M +$5.51M +35,540 New
MSFP
1236
Mark Sheptoff Financial Planning
Connecticut
$5.12M -$85.5K -552 -2%
FFWA
1237
FRG Family Wealth Advisors
Washington
$5.11M -$101K -652 -2%
PT
1238
Plimoth Trust
Massachusetts
$5.11M +$11.5K +74 +0.2%
SCP
1239
Shorepoint Capital Partners
Massachusetts
$5.1M +$18.9K +122 +0.3%
NAM
1240
NTV Asset Management
West Virginia
$5.1M -$44.6K -288 -0.8%
TFS
1241
Thoroughbred Financial Services
Tennessee
$5.09M -$14.7K -95 -0.3%
JCM
1242
Jacobi Capital Management
Pennsylvania
$5.08M -$251K -1,619 -4%
AWM
1243
Avior Wealth Management
Nebraska
$5.08M -$620K -4,002 -10%
HIP
1244
Harrell Investment Partners
Texas
$5.07M -$169K -1,090 -3%
DLCIG
1245
D.L. Carlson Investment Group
New Hampshire
$5.05M -$13.3K -86 -0.2%
PP
1246
Pacifica Partners
Canada
$5.05M +$792K +5,111 +17%
FCMT
1247
Founders Capital Management (Texas)
Texas
$5.04M -$102K -659 -2%
GIC
1248
Generali Investments CEE
Czech Republic
$5.04M +$5.4M +34,830 New
TI
1249
TrueMark Investments
Illinois
$5.03M +$1.77M +11,399 +49%
MDCM
1250
Morgan Dempsey Capital Management
Wisconsin
$5.01M -$1.03M -6,635 -16%

JNJ Hedge Fund Activity: Q4 2024 in Review

4,108 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2024, worth a combined $257B — down 7.5% from $278B a quarter earlier.

Buyers outnumbered sellers: 471 funds opened new JNJ positions and 177 closed out — a net gain of 294 holders — while 1,352 added to existing stakes and 1,937 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $729M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.38B.

  • 4,108 institutional investors held Johnson & Johnson (JNJ) as of Q4 2024, up from 3,885 in Q3 2024.
  • Funds reported $257B of Johnson & Johnson stock for Q4 2024, down 7.5% quarter-over-quarter.
  • 471 funds opened new Johnson & Johnson positions in Q4 2024 and 177 closed out, a net change of +294 holders.
  • The largest Johnson & Johnson buyer in Q4 2024 was Pinnacle Associates, an estimated $729M added.
  • The largest Johnson & Johnson seller in Q4 2024 was T. Rowe Price Associates, an estimated $1.38B sold.

Based on aggregated 13F filings for Q4 2024.